T-Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in T-Therapeutics?

T-Therapeutics has 9 investors including F-Prime And Tencent.

Q: When was the last funding round for T-Therapeutics?

T-Therapeutics closed its last funding round on obfuscated from a Series A round.

Q: How much funding has T-Therapeutics raised to date?

T-Therapeutics has raised obfuscated.

Overview

T-Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About T-Therapeutics

CB Rank

20995

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.

Founded

obfuscation

Private

Series A

Cambridge, Cambridgeshire, United Kingdom

51-100

t-therapeutics.com/

Biotechnology

Health Care

Medical

Funding Rounds

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Details

Legal Name

T-Therapeutics Ltd

Operating Status

Active

Company Type

For Profit

About the Company

T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .

Contact Email

contact@t-therapeutics.com

Predictions & Insights

Growth Insight

See this Growth Insight

T-Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

OpTiMus® Platform

A proprietary transgenic mouse platform that generates fully human T cell receptors (TCRs) with unique properties for therapeutic development.

TCR-Based Therapeutics Pipeline

A pipeline of first-in-class T cell receptor (TCR) therapeutics designed to target cancer and autoimmune diseases by redirecting patient T cells to recognize and kill diseased cells.

Research & Development

T-Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - T-Therapeutics	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - T-Therapeutics	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - T-Therapeutics	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - T-Therapeutics	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - T-Therapeutics	8	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - T-Therapeutics	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - T-Therapeutics	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - T-Therapeutics	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - T-Therapeutics	8	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - T-Therapeutics	8	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
F-Prime	—	Series A - T-Therapeutics	Nihal Sinha
F-Prime	—	Series A - T-Therapeutics	Nihal Sinha
F-Prime	—	Series A - T-Therapeutics	Nihal Sinha
F-Prime	—	Series A - T-Therapeutics	Nihal Sinha
F-Prime	—	Series A - T-Therapeutics	Nihal Sinha